PTPRD and cancer: The exogenous expression of PTPRD in human GBM and other cancer cell lines inhibited cell growth, which coincided with a substantial decrease in the expression levels of phosphorylated STAT3 (Y705) and, consequently, one of its downstream targets, suppressor of cytokine signaling 3 (SOCS3) [26].